A decision analysis model to assess the feasibility of the early detection of psychosis in the general population

Schizophrenia Research

Volumn 74, Issue 1, 2005, Pages 27-36

  Cougnard, Audrey ^a   Rachid Salmi, L ^a   Salamon, Roger ^b   Verdoux, Hélène ^a,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Decision analysis; Early detection; Feasibility; General population; Psychosis

Indexed keywords

ARTICLE; DECISION THEORY; EARLY DIAGNOSIS; MASS SCREENING; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; SENSITIVITY ANALYSIS;

EID: 13444249749     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.09.018     Document Type: Article

References (50)

1. S. Almond, and O. O'Donnell Cost analysis of the treatment of schizophrenia in the UK. A comparison of olanzapine and haloperidol PharmacoEconomics 13 1998 575 588
2. A. Breier, J.L. Schreiber, J. Dyer, and D. Pickar National Institute of Mental Health Longitudinal study of schizophrenia Arch. Gen. Psychiatry 48 1991 239 246
3. S.B. Cantor, S.J. Spann, R.J. Volk, M.P. Cardenas, and M.M. Warren Prostate cancer screening: a decision analysis J. Fam. Pract. 41 1995 33 41
4. D.J. Castle, M. Phelan, S. Wessely, and R.M. Murray Which patients with non-affective functional psychosis are not admitted at first psychiatric contact? Br. J. Psychiatry 165 1994 101 106
5. B.A. Cornblatt, T. Lencz, and J.M. Kane Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr. Res. 51 2001 31 38
6. A. Cougnard, L.R. Salmi, and H. Verdoux A decade of debate on early intervention in psychosis: a systematic review of screening criteria Schizophr. Res. 60 2003 91 93
7. DATA 3.0., 1997. Decision analysis by Tree Age software: release 3.0.
8. L.M. Davies, and M.F. Drummond Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom Br. J. Psychiatry 162 1993 38 42
9. A. Davies, P.C. Langley, N.A. Keks, S.V. Catts, T. Lambert, and I. Schweitzer Risperidone versus haloperidol. II: cost-effectiveness Clin. Ther. 20 1998 196 213
10. A.S. Detsky, G. Naglie, M.D. Krahn, D. Naimark, and D.A. Redelmeier Primer on medical decision analysis. Part 1: getting started Med. Decis. Mak. 17 1997 123 125
11. J. Edwards, and P.D. McGorry Implementing Early Intervention in Psychosis. A Guide to Establishing Early Psychosis Services Concept 2002 Martin Dunitz London
12. T.J. Gates Screening for cancer: evaluating the evidence Am. Fam. Phys. 63 2001 513 522
13. S. Hachter Decision analysis in psychiatry Br. J. Psychiatry 166 1995 184 190
14. M.S. Hanssen, R.V. Bijl, W. Vollebergh, and J. van Os Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatr. Scand. 107 2003 369 377
15. B.C. Ho, and N.C. Andreasen Long delays in seeking treatment for schizophrenia Lancet 24 2001 898 899
16. H.M. Inskip, E.C. Harris, and B. Barraclough Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia Br. J. Psychiatry 172 1998 35 37
17. A. Jablensky Schizophrenia recent epidemiological issues Epidemiol. Rev. 17 1995 10 20
18. A. Jablensky The 100-year epidemiology of schizophrenia Schizophr. Res. 28 1997 111 125
19. J.O. Johanessen Early recognition and intervention: the key to success in the treatment of schizophrenia? Dis. Manag. Clin. Outcomes 9 2001 317 327
20. J.O. Johannessen, T.H. McGlashan, T.K. Larsen, M. Horneland, I. Joa, S. Mardal, R. Kvebaek, S. Friis, I. Melle, S. Opjordsmoen, E. Simonsen, H. Ulrik, and P. Vaglum Early detection strategies for untreated first-episode psychosis Schizophr. Res. 51 2001 39 46
21. J. Klosterkötter, M. Hellmich, E.M. Steinmeyer, and F. Schultze-Lutter Diagnosing schizophrenia in the initial prodromal phase Arch. Gen. Psychiatry 58 2001 158 164
22. T.H. McGlashan, T.J. Miller, and S.W. Woods Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk Schizophr. Bull. 27 2001 563 570
23. P.D. McGorry, and J. Edwards The prevention of schizophrenia: what interventions are safe and effective? Schizophr. Bull. 28 2002 177 180
24. P.D. McGorry, B.S. Singh, D.L. Copolov, I. Kaplan, C.R. Dossetor, and R.J. van Riel The Royal Park Multidiagnostic Instrument for Psychosis: Pt II. Development, reliability and validity Schizophr. Bull. 16 1990 517 536
25. P.D. McGorry, J. Edwards, C. Mihalopoulos, S.M. Harrigan, and H.J. Jackson EPPIC: an evolving system of early detection and optimal management Schizophr. Bull. 22 1996 305 326
26. C.H. Miller, F. Mohr, D. Umbricht, M. Woerner, W.W. Fleischhacker, and J.A. Lieberman The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics J. Clin. Psychiatry 59 1998 69 75
27. T.J. Miller, T.H. McGlashan, S.W. Woods, K. Stein, N. Driesen, C.M. Corcoran, R. Hoffman, and L. Davidson Symptom assessment in schizophrenic prodromal states Psychiatr. Q. 70 1999 273 287
28. A.S. Morrison Screening in Chronic Disease 1985 Oxford University Press New York
29. P.B. Mortensen, and K. Juel Mortality and causes of death in schizophrenic patients in Denmark Acta Psychiatr. Scand. 81 1990 372 377
30. P.I. Oh, M. Iskedjian, A. Addis, K. Lanctot, and T.R. Einarson Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis Can. J. Clin. Pharamacol. 8 2001 199 206
31. M.M. Ohayon, M. Caulet, R.G. Priest, and C. Guilleminault Psychotropic medication consumption patterns in the UK general population J. Clin. Epidemiol. 51 1998 273 283
32. B.I. O'Toole Screening for low prevalence disorders Aust. N. Z. J. Psychiatry 34 2000 s39 s46 (Suppl.)
33. C.S. Palmer, D.A. Revicki, L.A. Genduso, S.H. Hamilton, and R.E. Brown A cost-effectiveness clinical decision analysis model for schizophrenia Am. J. Manag. Care 4 1998 345 355
34. C.S. Palmer, E. Brunner, L.G. Ruiz-Flores, F. Paez-Agraz, and D.A. Revicki A cost-effectiveness clinical decision analysis model for treatment of schizophrenia Arch. Med. Res. 33 2002 572 580
35. A. Pelosi, and M. Birchwood Is early intervention for psychosis a waste of valuable resources? Br. J. Psychiatry 182 2003 196 198
36. P. Power, K. Elkins, S. Adlard, C. Curry, P. McGorry, and S. Harrigan Analysis of the initial treatment phase in first-episode psychosis Br. J. Psychiatry 172 1998 71 76
37. A.E. Raffle, B. Alden, M. Quinn, P.J. Babb, and M.T. Brett Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modeling of cases and deaths prevented BMJ 326 2003 901
38. C.M. Rembold Number needed to screen: development of a statistic for disease screening BMJ 317 1998 307 312
39. W.S. Richardson, and A.S. Detsky How to use a clinical decision analysis J. Am. Med. Assoc. 273 1995 1292 1295
40. J.M. Riviera, F. Garcia-Bragado, L.M. Iriarte, F. Lozno-Gutierrez, V. Salgado, and J. Andreu Neuroleptic malignant syndrome: analysis of 9 cases Med. Clin. 94 1990 121 125
41. G. Rose The Strategy of Preventive Medicine 1992 Oxford University Press New York
42. D.L. Sackett, and W.W. Holland Controversy in the detection of disease Lancet 2 1975 357 359
43. M.M. Schapira, D.B. Matchar, and M.J. Young The effectiveness of ovarian cancer screening. A decision analysis model Ann. Intern. Med. 118 1993 838 843
44. S.P. Singh, T. Croudace, S. Amin, R. Kwiecinski, I. Medley, P.B. Jones, and G. Harrison Three-year outcome of first-episode psychoses in an established community psychiatric service Br. J. Psychiatry 176 2000 210 216
45. H. Verdoux, and A. Cougnard The early detection and treatment controversy in schizophrenia research Curr. Opin. Psychiatry 16 2003 175 179
46. H. Verdoux, S. Maurice-Tison, B. Gay, J. Van Os, R. Salamon, and M.L. Bourgeois A survey of delusional ideation in primary-care patients Psychol. Med. 28 1998 127 134
47. R. Warner The prevention of schizophrenia: what interventions are safe and effective? Schizophr. Bull. 27 2001 551 562
48. P.J. Weiden, and M. Olfson Cost of relapse in schizophrenia Schizophr. Bull. 21 1995 491 529
49. D.R. Wolpaw Early detection in lung cancer. Case finding and screening Med. Clin. North Am. 80 1996 63 82
50. S. Woods, T.J. Miller, L. Davidson, K.A. Hawkins, M.J. Sernyak, and T.H. McGlashan Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients Schizophr. Res. 52 2001 21 27